The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease

Kidney International, Supplement

Volumn 57, Issue 75, 2000, Pages

  Klahr, Saulo ^a   Morrissey, Jeremiah J ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Angiotensin II; Nuclear factor B; Tumor growth factor ; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; BASIC FIBROBLAST GROWTH FACTOR; CELL ADHESION MOLECULE; CHEMOATTRACTANT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN; RENIN; SOMATOMEDIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASOACTIVE AGENT; ANGIOTENSIN DERIVATIVE; GROWTH PROMOTOR;

CONFERENCE PAPER; HUMAN; KIDNEY FAILURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; DISEASE COURSE; KIDNEY DISEASE; PHYSIOLOGY; REVIEW;

ANGIOTENSINS; DISEASE PROGRESSION; GROWTH SUBSTANCES; HUMANS; KIDNEY DISEASES; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034119307     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.07509.x     Document Type: Conference Paper

References (67)

1. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Eng J Med 318:1657-1666, 1988
2. KLAHR S, MORRISSEY JJ: Angiotensin II and Gene Expression in the Kidney. Am J Kidney Dis 31:171-176, 1998
3. SCHMITZ D, BERK BC: Angiotensin II signal transduction stimulation of multiple mitogen activated protein kinase pathways. Trends Endocrinol Metab 8:261-266, 1997
4. WARNHOLTZ A, NICKENIG G, SCHULZ E, MACHARZINA R, BRÄSEN JH, SKATCHKOV M, HEITZER T, STASCH JP, GRIENDLING KK, HARRISON DG, BÖHM M, MEINERTZ T, MÜNZEL T: Increased NADH-oxidase-mediated super-oxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 99:2027-2033, 1999
5. LI J, BRAZIER AR: Angiotensinogen gene activation by angiotensin II is mediated by the Rel A (Nuclear Factor-κB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10:252-264, 1996
6. BRASIER AR, LIJ: Mechanisms for inducible control of angiotensinogen gene transcription. Hypertension 27 (2):465-475, 1996
7. BRASIER AR, LI J, WIMBISH KA: Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. Hypertension 27:1009-1017, 1996
8. MORRISSEY JJ, KLAHR S: Enalapril decreases nuclear factor ΚB activation in the kidney with ureteral obstruction. Kidney Int 52:926-933, 1997
9. ROBERTS AM, SPORN MB: Transforming growth factor-β. Adv Cancer Res 51:107-145, 1988
10. GIBBONS GH, PRATT RE, DZAU VJ: Vascular smooth muscle hypertrophy. Autocrine transforming growth factor β1 expression determines growth response to angiotensin II. J Clin Invest 90:451-461, 1992
11. KANETO H, MORRISSEY J, KLAHR S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ligation. Kidney Int 44:313-321, 1993
12. MUNGER JS, HARPEL JG, GLEIZES PE, MAZZIERI R, NUNES I, RIFKIN DB: Latent transforming growth faclor-β: structural features and mechanisms of activation. Kidney Int 51:1376-1382, 1997
13. BÖTTINGER EP, LETTERIO JJ, ROBERTS AR: Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 51:1355-1360, 1997
14. CHUA CC, HAMDY RC, CHUA BH: Regulation of thrombospondin-1 production by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1357:209-214, 1997
15. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
16. SANDERSON N, FACTOR V, NAGY P, KOPP J, KONDAIAH P, WAKEFIELD L, ROBERTS AB, SPORN MB, THORGEIRSSON SS: Hepatic expression of mature transforming growth factor beta-1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 92:2572-2576, 1995
17. SCHNERMANN JB, ZHU XL, SHU X, YANO T, HUANG YG, KRETZLER M, BRIGGS JP: Regulation of endothelin production and secretion in cultured collecting duct cells by endogenous transforming growth factor-beta. Endocrinology 137:5000-5008, 1996
18. HOCHER B, THÖNE-REINEKI C, ROHMEISS P, SCHMAGER F, SLOWINSKI T, BURSI V, SIEGMUND F, QUERTERMOUS T, BAUER C, NEUMAYER HH, SCHLEUNING WD, THEURING F: Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts hut not hypertension. J Clin Invest 99:1380-1389, 1997
19. KUNCIO GS, NEILSON EG, HAVERTY T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
20. SHARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
21. BORDER WA, RUOSLAHTI E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
22. SHARMA K, ZIYADEH FN, ALZAHABI B, MCGOWAN TA, KAPOOR S, KURNICK BRC, WEISBERG LS: Increased renal production of transforming growth factor-β1 in patients with type II diabetes mellitus. Diabetes 46:854-859, 1997
23. SHANKLAND SJ, SCHOLEY JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
24. WOLF G, NEILSON EG: Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int 39:401-420, 1991
25. EDDY AA: Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7:2495-2508, 1996
26. FOGO A, ICHIKAWA I: Evidence for the central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol 9:329-342, 1989
27. EL NAHAS AM: Growth factors and glomerular sclerosis. Kidney Int 41 (Suppl. 36):S15-S20, 1992
28. YOUNG BA, JOHNSON RJ, ALPERS CA, ENG E, GORDON K, FLOEGE J, COUSER WG: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47:935-944, 1995
29. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, NAGAOKA I, TOMINO Y, KOIDE H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
30. INABA T, ISHIBASH IS, GOTODA T, KAWAMURA M, MORINO N, NOJIMA Y, KAWAKAMI M, YAZAKI Y, YAMADA N: Enhanced expression of platelet-derived growth factor-β receptor by high glucose. Involvement of platelet-derived growth factor in angiopathy. Diabetes 45:507-512, 1996
31. THROCKMORTON DC, BRODGEN AP, MIN B, RASMUSSEN H, KASHGARIAN M: PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48:111-117, 1995
32. LIU Y, TOLBERT WM, SUN AM, DWORKIN ED: In vivo and in vitro evidence for increased expression of HGF receptor in kidney of diabetic rats. Am J Physiol 271:F1202-F1210, 1996
33. MORISHITA R, NAKAMURA S, NAKAMURA Y, AOK IM, MORIGUCHI A, KIDA I, YO Y, MATSUMOTO K, NAKAMURA T, HIGAKI J, OGIHARA T: Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes 46:138-142, 1997
34. LIU Y, TOLBERT EM, LIN L, THURSBY MA, SUN AM, NAKAMURA T, DWORKIN LD: Up-regulation of hepatocyte growth factor receptor: amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int 55:442-453, 1999
35. MILLER SB, MARTIN DR, KISSANE J, HAMMERMAN MR: Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol (Renal Fluid Electrolyte Physiol 35):F129-F134, 1994
36. LIU Y: Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms Am J Physiol: (Renal Physiol 277): F624-F633, 1999
37. HAMMERMAN MR: The growth hormone-insulin-like growth factor axis in kidney. Am J Physiol 257:F503-F514, 1989
38. PHILLIP M, SEGEVE Y, ZUNG A, KOWARSKI AA, WERNER H, ROBERTS CT, LEROITH D, LADAS J, MULRONEY SE: The accumulation of IGF-I in kidneys of streptozotocin-diabetic rats is not associated with elevated plasma GH or IGF-I levels. Endocrine 3:689-693, 1995
39. WERNER H, SHEN-ORR Z, STANNARD B, BURGUERA B, ROBERTS CT, LEROITH D: Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney. Diabetes 39:1490-1497, 1990
40. SUGIMOTO H, SHIKATA K, MAKINO H, OTA K, OTA Z: Increased gene expression of insulin-like growth factor-I receptor in experimental diabetic rat glomeruli. Nephron 72:648-653, 1996
41. FLYVBJERG A, MARSHALL SM, FRYSTYK J, HANSEN KW, HARRIS AG, ORSKOV H: Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion. Kidney Int 41:805-812, 1992
42. FELD SM, HIRSCHBERG R, ARTISHEVSKY A, NAST C, ADLER SG: Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int 48:45-51, 1995
43. BLAZER-YOST BL, WATANABE M, HAVERTY TP, ZIYADEH FN: Role of insulin and IGF1 receptors in proliferation of cultured renal proximal tubule cells. Biochim Biophys Acta 113:329-335, 1992
44. EGIDO J, GOMEZ-CHIARRI M, ORTIZ A, BUSTOS C, ALONSO J, GOMEZ-GUERRERO C, GOMEZ-GARRE P, LOPEZ-ARMADA MJ, PLAZA J, GONZALEZ E: Role of tumor necrosis factor-a in the pathogenesis of glomerular diseases. Kidney Int 43 (Suppl. 39):S59-S-64, 1993
45. BAUD L, FOUQUERAY B, PHILIPPE C, AMRAM A: Tumor necrosis factor α and mesangial cells. Kidney Int 41:600-603, 1992
46. ORITZ A, BUSTOS C, ALCAZAR A, LOPEZ-ARMADA MJ, PLAZA JU, GONZALEZ E, EGIDO J: Involvement of tumor necrosis factor-α in the pathogenesis of experimental and human glomerulonephritis, in Advances in Nephrology, edited by GRUNFELD JP, BACH JF, KREIS H, MAXWELL MH, St. Louis, Mosby, 1995: 53-77
47. WUIHRICH RP, GLIMCHER LH, YUI MA, JEVNIKAR AM, DUMAS SE, KELLEY VE: MHC class II antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37:783-792, 1990
48. KANETO H, MORRISSEY J, MCCRACKEN R, ISHIDOYA S, REYES A, KLAHR S: The expression of mRNA for tumor necrosis factor-α increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrology 2:161-166, 1996
49. WOLF G, ABERLE S, THAISS F, NELSON PJ, KAENSKY AM, NEILSON EG, STRAHL RA: TNF-α induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int 44:795-804, 1993
50. MULLIGAN MS, JOHNSON KJ, TODD RF, ISSEKUTZ TB, MIYASAKA M, TAMATANI T, SMITH CW, ANDERSON DC, WARD PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91:577-587, 1993
51. LARRICK JW, WRIGHT SC: Cytotoxic mechanism of tumor necrosis factor-a. FASEB J 4:3215-3223, 1990
52. LASTER SM, WOOD JG, GOODING LR: Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J Immunol 141:2629-2634, 1988
53. ITOH N, YONEHARA S, ISHII A, YONEHARA M, MIZUSHIMA SI, SHAMESHIMA M, HASE A, SETO Y, NAGATA S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
54. BAEURLE PA, HENKEL T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179, 1994
55. BARNES PJ, KARIN M: Nuclear factor-κ: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
56. WENDT T, ZHANG YM, BIERHAUS A, KRIEGSMANN J, DENG Y, WALDHERR R, TESKE T, LUTER T, FDNFSTUK R, NAWROTH PP, STEIN G: Tissue factor expression in an animal model of hydronephrosis. Nephrol Dial Transplant 10:1820-1828, 1995
57. LENTSCH AB, SHANLEY TP, SARMA V, WARD PA: In vivo suppression of NF-κB and preservation of IκBα by interleukin-10 and interleukin-13. J Clin Invest 100:2443-2448, 1997
58. MIZRA A, LIU S-L, FRIZELL E, ZHU J, MADDUKURI S, MARTINEZ J, DAVIES P, SCHWARTING R, NORTON P, ZERN MA: A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-κB Am J Physiol 272 (Gastrointest Liver Physiol 35):G281-G288, 1997
59. BUTLER W: The nature and significance of osteopontin. Connective Tissue Res 23:123-136, 1989
60. PICHLER R, GIACHELLI CM, LOMBARDI D, PIPPIN J, GORDON K, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Tubulointerstitial disease in glomerulonephritis; potential role of osteopontin (uropontin). Am J Pathol 144:915-926, 1994
61. JOHNSON TS, GRIFFIN M, THOMAS GL, SKILL J, COX A, YANG B, NICHOLAS B, BIRCKBICHLER PJ, MUCHANETA-KUBARA C, EL NAHAS AM: The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99:2950-2960, 1997
62. LEE KS, BUCK M, HOUGLUM K, CHOJKIER M: Activation of hepatic stellate cells by TGF-a and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461-2468, 1995
63. NAGLE RB, JOHNSON ME, JERVIS HR: Proliferation of renal interstitial cells following injury induced by ureteral obstruction. Lab Invest 35:18-22, 1976
64. PEDAGOGOS E, HEWITSON T, FRASER I, NICHOLLS K, BECKER G: Myofibroblasts and arteriolar sclerosis in human diabetic nephropathy. Am J Kidney Dis 29:912-918, 1997
65. STRUTZ F, OKADA H, LO CW, DANOFF T, CARONE RL, TOMASZEWSKI JE, NEILSON EG: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
66. TULCHINSKY E, PROKHORTCHOUK E, GEORGIEV G, LUKANIDIN E: A κ-B-related binding site is an integral part of the mtsl gene composite enhancer element located in the first intron of the gene. J Biol Chem 272:4828-4835, 1997
67. MORRISSEY JJ, ISHIDOYA S, MCCRACKEN R, KLAHR S: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 10:2202-2212, 1996